Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and news announcements for the European Society of Cardiology (ESC) Congress, which runs from August 29 to September 2 in Barcelona. Highlights include final results from the MADIT-CRT trial and two-year results from the SYNTAX trial.
"Boston Scientific is proud to be the exclusive sponsor of the landmark MADIT-CRT trial, and we look forward to the presentation of the final data at ESC," said Ray Elliott, President and Chief Executive Officer of Boston Scientific. "MADIT-CRT is breaking new ground by demonstrating that early intervention with cardiac resynchronization defibrillation therapy (CRT-D) slows the progression of heart failure when compared to standard implantable cardioverter defibrillator (ICD) therapy. We are also looking forward to the presentation of two-year data from our SYNTAX trial, comparing the use of percutaneous coronary intervention (PCI) using the TAXUS(R) Express2(R) Paclitaxel-Eluting Coronary Stent System to coronary artery bypass graft (CABG) surgery in patients with complex disease. We are hopeful these results will build on the one-year data, which showed comparable safety outcomes for PCI and CABG."
Details of the Company's activities at ESC are below.
Schedule of Events (All times are local Barcelona; all events are held at the Fira Gran Via Convention Center.)
Sunday, August 30
- HORIZONS-AMI Trial Results. One-year data from the HORIZONS-AMI trial will be presented in a poster session at 8:30 a.m. The trial was designed to determine the safety and efficacy of the TAXUS Express2 Paclitaxel-Eluting Coronary Stent System compared to bare-metal stenting in patients experiencing an acute myocardial infarction (AMI). Results will focus on the relative impact of ischemic complications and varying definitions of major bleeding on one-year mortality in patients with AMI.
Monday, August 31
- Clinical Seminar - The SYNTAX Trial: One Year On. The Company will sponsor a clinical seminar chaired by Miguel Sousa Uva, M.D., and Antonio Colombo, M.D., from 4:30-6:00 p.m. in the Madrid Room. Discussion topics will include the view of the non-interventional cardiologist and conclusions from subgroup analyses.
Tuesday, September 1